X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (625) 625
female (418) 418
male (409) 409
splenic neoplasms - pathology (292) 292
animals (277) 277
middle aged (274) 274
index medicus (255) 255
splenic neoplasms - immunology (252) 252
aged (228) 228
adult (208) 208
oncology (189) 189
mice (181) 181
hematology (156) 156
spleen (148) 148
pathology (118) 118
splenic neoplasms - genetics (113) 113
splenectomy (112) 112
spleen - pathology (106) 106
lymphomas (102) 102
splenic neoplasms - diagnosis (101) 101
immunophenotyping (93) 93
cancer (87) 87
immunohistochemistry (81) 81
surgery (81) 81
immunology (79) 79
lymphoma (79) 79
diagnosis, differential (78) 78
neoplasm transplantation (78) 78
aged, 80 and over (77) 77
liver neoplasms - pathology (74) 74
splenic neoplasms - secondary (73) 73
villous lymphocytes (72) 72
treatment outcome (65) 65
medicine & public health (62) 62
spleen - immunology (61) 61
diagnosis (56) 56
b-cell lymphoma (55) 55
tumors (55) 55
liver neoplasms - immunology (54) 54
lymphoma - immunology (54) 54
lymphoma, b-cell - pathology (53) 53
adolescent (52) 52
lymphoma, b-cell - immunology (50) 50
prognosis (49) 49
splenic neoplasms - drug therapy (49) 49
lymphoma, t-cell - pathology (48) 48
splenic neoplasms - complications (48) 48
flow cytometry (46) 46
lymphoma, t-cell - immunology (46) 46
analysis (45) 45
chronic lymphocytic-leukemia (45) 45
lymph nodes - pathology (45) 45
lymphoma, b-cell, marginal zone - pathology (45) 45
retrospective studies (45) 45
leukemia (44) 44
splenic neoplasms - surgery (43) 43
antineoplastic combined chemotherapy protocols - therapeutic use (42) 42
disease (42) 42
splenic marginal zone lymphoma (42) 42
expression (40) 40
health aspects (40) 40
lymphoma - pathology (40) 40
splenic lymphoma (40) 40
splenic neoplasms - therapy (40) 40
chemotherapy (39) 39
lymphocytes (39) 39
splenic neoplasms - metabolism (39) 39
tomography, x-ray computed (39) 39
biopsy (38) 38
care and treatment (37) 37
follow-up studies (37) 37
mice, inbred c57bl (37) 37
child (36) 36
gastroenterology & hepatology (36) 36
lymphoma, b-cell, marginal zone - genetics (35) 35
mice, inbred balb c (35) 35
research article (35) 35
risk factors (35) 35
liver neoplasms - secondary (34) 34
mutation (34) 34
rats (34) 34
time factors (34) 34
b-lymphocytes - immunology (33) 33
bone marrow - pathology (33) 33
research (33) 33
cell biology (32) 32
fatal outcome (32) 32
liver (32) 32
splenic neoplasms (32) 32
splenic neoplasms - veterinary (32) 32
dogs (31) 31
metastasis (31) 31
genetic aspects (30) 30
non-hodgkin's lymphomas (30) 30
t cells (30) 30
lymphoma, b-cell - genetics (29) 29
medicine, general & internal (29) 29
non-hodgkins-lymphoma (29) 29
antineoplastic agents - therapeutic use (28) 28
liver neoplasms - diagnosis (28) 28
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (805) 805
French (17) 17
Chinese (13) 13
Japanese (13) 13
German (10) 10
Russian (7) 7
Hungarian (3) 3
Spanish (2) 2
Danish (1) 1
Italian (1) 1
Portuguese (1) 1
Romanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 05/2016, Volume 40, Issue 5, pp. 676 - 688
Hepatosplenic T-cell lymphoma (HSTCL) is a rare type of lymphoma. Patients have a poor prognosis, and there is no standard of care. We evaluated 28 HSTCL... 
Stem cell transplant | Hepatosplenic T-cell lymphoma | Prognostic factors | SURGERY | stem cell transplant | ENTITY | hepatosplenic T-cell lymphoma | GRANULAR LYMPHOCYTIC-LEUKEMIA | BONE-MARROW | prognostic factors | THERAPIES | PATHOLOGY | PERIPHERAL-BLOOD INVOLVEMENT | SEZARY-SYNDROME | TUMORS | Immunohistochemistry | Humans | Middle Aged | Child, Preschool | Male | Receptors, Antigen, T-Cell, alpha-beta - immunology | Receptors, Antigen, T-Cell, gamma-delta - genetics | Isochromosomes | Young Adult | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Child | Genetic Predisposition to Disease | Liver Neoplasms - genetics | Risk Factors | Splenic Neoplasms - genetics | In Situ Hybridization, Fluorescence | Liver Neoplasms - immunology | Receptors, Antigen, T-Cell, gamma-delta - immunology | Bone Marrow Examination | Chromosomes, Human, Pair 7 | Lymphoma, T-Cell - drug therapy | Phenotype | Trisomy - genetics | Adolescent | Therapeutics | Biomarkers, Tumor - genetics | Hepatomegaly - pathology | Chromosomes, Human, Pair 8 - genetics | Lymphoma, T-Cell - immunology | Splenic Neoplasms - immunology | United States | Splenomegaly - pathology | Liver Neoplasms - mortality | Splenic Neoplasms - mortality | Adult | Female | Retrospective Studies | Splenic Neoplasms - drug therapy | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Proportional Hazards Models | Lymphoma, T-Cell - genetics | Receptors, Antigen, T-Cell, alpha-beta - genetics | Disease-Free Survival | Splenic Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Bone Marrow - pathology | Lymphoma, T-Cell - pathology | Aged | Lymphoma, T-Cell - mortality
Journal Article
Journal of Immunotherapy, ISSN 1524-9557, 06/2012, Volume 35, Issue 5, pp. 400 - 408
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) can mediate objective and durable tumor regressions in patients with metastatic melanoma.... 
HLA DR | CD4 | Tumor-infiltration lymphocytes (TIL) | Immunotherapy | T-helper cell (Th) | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOLOGY | IDENTIFICATION | TRANSFER THERAPY | METASTATIC MELANOMA | tumor-infiltration lymphocytes (TIL) | ADOPTIVE TRANSFER | ONCOLOGY | CANCER REGRESSION | AUTOIMMUNITY | immunotherapy | CD4(+) | REGULATORY T-CELLS | ANTIGEN | CD8-Positive T-Lymphocytes - cytology | Splenic Neoplasms - immunology | Splenic Neoplasms - therapy | Cell Proliferation | Humans | Interleukin-2 - therapeutic use | Liver Neoplasms - therapy | Lymphocyte Depletion | CD4-Positive T-Lymphocytes - immunology | Interleukin-2 - administration & dosage | Female | Tumor Cells, Cultured | Liver Neoplasms - secondary | Skin Neoplasms - pathology | Immunotherapy, Adoptive - methods | Skin Neoplasms - immunology | Skin Neoplasms - therapy | CD4-Positive T-Lymphocytes - cytology | Lymphocytes, Tumor-Infiltrating - transplantation | Liver Neoplasms - immunology | Melanoma - pathology | Organ Specificity | CD4-Positive T-Lymphocytes - transplantation | Melanoma - immunology | Interferon-gamma - immunology | HLA-DR Antigens - immunology | CD8-Positive T-Lymphocytes - immunology | Melanoma - therapy | Splenic Neoplasms - secondary | Interferon-gamma - biosynthesis | Lymphocytes, Tumor-Infiltrating - immunology | Spleen | Liver diseases | Tumor-infiltrating lymphocytes | CD8 antigen | Melanoma | Antibodies | Lymphocytes T | CD4 antigen | Metastases | Interleukin 2 | gamma -Interferon | Histocompatibility antigen HLA
Journal Article
Leukemia, ISSN 0887-6924, 01/2013, Volume 27, Issue 1, pp. 183 - 189
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2011, Volume 53, Issue 8, pp. 798 - 806
Journal Article
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2012, Volume 2012, pp. 426 - 432
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2011, Volume 83, Issue 2, pp. 283 - 292
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 12/2016, Volume 22, Issue 47, pp. 10465 - 10470
Journal Article
Blood, ISSN 0006-4971, 09/2011, Volume 118, Issue 12, pp. 3331 - 3339
One-third of all splenic marginal zone lymphomas (SMZL) use the IgH VH1-02 gene. These cases are usually not associated with hepatitis C virus infection. Of... 
REGRESSION | REPERTOIRE | B-CELL LYMPHOMA | HEAVY-CHAIN | MEMORY | VILLOUS LYMPHOCYTES | 7Q DELETION | MONOCLONAL-ANTIBODIES | RECEPTORS | HEMATOLOGY | ANTIGEN SELECTION | Immunohistochemistry | Antibody Specificity | Splenic Neoplasms - immunology | Spleen - immunology | Antibodies - metabolism | Hepacivirus - immunology | Humans | Middle Aged | Immunoglobulin Variable Region - metabolism | Blood Proteins - immunology | Male | Immunoglobulin Variable Region - immunology | Blood Proteins - metabolism | Immunoglobulin Light Chains - genetics | Hepatitis C - immunology | Transfection | Isoantigens - immunology | Karyotyping | Cloning, Molecular | HEK293 Cells | Antibodies - immunology | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Rearrangement - immunology | Spleen - pathology | Immunoglobulin Light Chains - immunology | Recombinant Proteins - metabolism | Isoantigens - metabolism | Enzyme-Linked Immunosorbent Assay | Splenic Neoplasms - genetics | Lymphoma, B-Cell, Marginal Zone - immunology | Immunophenotyping | Recombinant Proteins - genetics | Immunoglobulin Light Chains - metabolism | Lymphoma, B-Cell, Marginal Zone - genetics | Splenic Neoplasms - pathology | Recombinant Proteins - immunology | Spleen - metabolism | Hepatitis C - virology | Protein Binding | Antibodies - genetics | Hepacivirus - growth & development | Immunoglobulin Variable Region - genetics
Journal Article